Thermo Fisher Scientific · 8 hours ago
Scientist III
Thermo Fisher Scientific is a leading company dedicated to making the world healthier, cleaner, and safer. They are seeking a Scientist III to join their R&D team, where the successful candidate will lead projects in developing next-generation sequencing applications and diagnostic assays, while collaborating across multidisciplinary teams to address complex scientific challenges.
BioinformaticsBiotechnologyCloud Data ServicesConsultingHealth CareLife ScienceManagement Information SystemsOffice SuppliesPrecision Medicine
Responsibilities
Independently design, execute, and interpret complex experiments to support development, validation, lifecycle management, and limited on-market support of companion diagnostics, primarily the Oncomine Dx Express Test
Perform hands-on laboratory work, including NGS sample preparation, assay execution, data review, and troubleshooting, in a regulated CDx environment
Analyze and interpret sequencing and assay performance data; ensure data integrity and compliance with design controls and CDx regulatory requirements
Develop clear, high-quality technical documentation (protocols, reports, design history and validation deliverables)
Collaborate and communicate results with cross-functional teams (R&D, Regulatory Affairs, Quality, Program Management)
Contribute to method optimization, assay robustness, risk mitigation, and support verification, validation, and change management activities
Provide technical leadership, mentor junior scientists, and support root-cause investigations and CAPAs as needed
Ensure compliance with FDA, IVDR, and internal quality system requirements while proactively identifying and resolving scientific and technical challenges to keep CDx programs on track
Qualification
Required
Must be legally authorized to work in the United States without sponsorship
Advanced Degree plus 3+ years of experience, or bachelor's degree plus 5+ years of experience in molecular biology techniques including DNA/RNA handling, PCR, qPCR, and nucleic acid quantification
Proven expertise in next-generation sequencing technologies, library preparation, and workflow optimization
Experience working in regulated environments (ISO 13485, 21 CFR Part 820)
Strong understanding of experimental design, data analysis, and statistical methods
Proficiency with bioinformatics tools and data visualization software (JMP, R, Python)
Experience with automated liquid handling systems and laboratory automation
Demonstrated ability to troubleshoot complex technical issues
Strong documentation skills including detailed lab notebooks and technical reports
Excellent verbal and written communication abilities for presenting to diverse audiences
Experience in project leadership and cross-functional collaboration
Experience mentoring scientists and coordinating team activities
Ability to work in BSL2 laboratory environment
Strong organizational and time management skills
Collaborative mindset with ability to work independently and as part of a team
Preferred
Preferred Fields of Study: Molecular Biology, Biochemistry, Biomedical Engineering, or related life sciences field
Benefits
A choice of national medical and dental plans, and a national vision plan, including health incentive programs
Employee assistance and family support programs, including commuter benefits and tuition reimbursement
At least 120 hours paid time off (PTO), 10 paid holidays annually, paid parental leave (3 weeks for bonding and 8 weeks for caregiver leave), accident and life insurance, and short- and long-term disability in accordance with company policy
Retirement and savings programs, such as our competitive 401(k) U.S. retirement savings plan
Employees’ Stock Purchase Plan (ESPP) offers eligible colleagues the opportunity to purchase company stock at a discount
Company
Thermo Fisher Scientific
Thermo Fisher Scientific is a biotechnology and laboratory equipment company that provides a wide range of scientific products and services.
Funding
Current Stage
Public CompanyTotal Funding
$15.97BKey Investors
National Grid
2025-11-24Post Ipo Debt· $2.42B
2025-09-30Post Ipo Debt· $2.5B
2023-08-07Post Ipo Debt· $2.95B
Leadership Team
Recent News
Crunchbase News
2025-12-31
2025-12-25
MarketScreener
2025-12-19
Company data provided by crunchbase